All trials - page: 289

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT04726891Feasibility of the First Known Adaptive Intervention for People With SCIUniversity of Alabama at Birmingham
  • Age 18 - 71 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • ≥ 1 years
  • be a wheelchair user and able to use arms for exercise.
Ended36NARehabilitationArm/hand function26 June 202227 January 20211
NCT04727866Brain Plus Spinal Stimulation for Cervical SCIBronx VA Medical Center
  • Age 18 - 75 yrs
  • Level C1-C8
  • AIS A, B, C, D
  • ≥ 12 months
  • NOT have an implanted device, e.g. stimulator or pacemaker
Ended24NATechnologyArm/hand function04 January 202127 January 20212
NCT04736849Epidural and Dorsal Root Stimulation in Humans With Spinal Cord InjuryMayo Clinic
  • Age ≥ 22 yrs
  • Level C7-T10
  • AIS A, B, C, D
  • ≥ 1 years
  • NOT have a body mass > 113 kg (250 pounds)
  • NOT have a history of cardiopulmonary disorder
  • NOT have a history of seizures
Ended22NATechnologyGeneral health24 September 202103 February 20211
NCT04807764Transspinal Stimulation Plus Locomotor Training for SCICity University of New York
  • Age 18 - 70 yrs
  • Level C1-T9
  • AIS C, D
  • 6 months - 70 years
  • NOT have an implanted device, e.g. pacemaker
  • NOT have cardiopulmonary disease or cognitive impairment
  • NOT have other neurological disorders (e.g., peripheral neuropathy)
  • NOT have history of seizures
Ended14NATechnologyStanding/walking/mobility01 August 202119 March 20213
NCT04809987Effectiveness of Virtual Gait System Intervention in Motor Function in People with Incomplete Spinal Cord Injury.University of Valencia
  • Age 16 - 99 yrs
  • Level C1-S5
  • AIS C, D
  • ≤ 99 years
  • NOT have other nervous system alterations
  • NOT have a vestibular disease
Active38NARehabilitationStanding/walking/mobility30 January 202122 March 20212
NCT04812431Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCIS.Biomedics Co., Ltd.
  • Age 18 - 65 yrs
  • Level C4-C7
  • AIS A
  • 7 days - 60 days
  • NOT have penetrating injury, e.g. gunshot or knife wound
  • NOT have history of malignant tumor
  • NOT have immunodeficiency
  • NOT have unstable or untreated psychiatric disorder
Recruiting5PHASE1, PHASE2Biological/cell basedGeneral health23 September 202123 March 20214